From the Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, FL (N.A., D.R.Y., K.W., H.E.G., C.M.G., E.M.-L., S.K., C.D., S.A.O., T.R., R.L.S., J.G.R.).
Division of Neurology, Delray Medical Center, FL (N.M.-K.).
Stroke. 2019 Aug;50(8):2101-2107. doi: 10.1161/STROKEAHA.118.023893. Epub 2019 Jul 15.
Background and Purpose- We aimed to evaluate the current practice patterns, safety and outcomes of patients who receive endovascular therapy (EVT) having mild neurological symptoms. Methods- From Jan 2010 to Jan 2018, 127,794 ischemic stroke patients were enrolled in the Florida-Puerto Rico Stroke Registry. Patients presenting within 24 hours of symptoms who received EVT were classified into mild (National Institutes of Health Stroke Scale [NIHSS] ≤5) or moderate/severe (NIHSS>5) categories. Differences in clinical characteristics and outcomes were evaluated using multivariable logistic regression. Results- Among 4110 EVT patients (median age, 73 [interquartile range=20] years; 50% women), 446 (11%) had NIHSS ≤5. Compared with NIHSS >5, those with NIHSS ≤5 arrived later to the hospital (median, 138 versus 101 minutes), were less likely to receive intravenous alteplase (30% versus 43%), had a longer door-to-puncture time (median, 167 versus 115 minutes) and more likely treated in South Florida (64% versus 53%). In multivariable analysis younger age, private insurance (versus Medicare), history of hypertension, prior independent ambulation and hospital size were independent characteristics associated with NIHSS ≤5. Among EVT patients with NIHSS ≤5, 76% were discharged home/rehabilitation and 64% were able to ambulate independently at discharge as compared with 53% and 32% of patients with NIHSS >5. Symptomatic intracerebral hemorrhage occurred in 4% of mild stroke EVT patients and 6.4% in those with NIHSS >5. Conclusions- Despite lack of evidence-based recommendations, 11% of patients receiving EVT in clinical practice have mild neurological presentations. Individual, hospital and geographic disparities are observed among endovascularly treated patients based on the severity of clinical symptoms. Our data suggest safety and overall favorable outcomes for EVT patients with mild stroke.
背景与目的-我们旨在评估接受血管内治疗(EVT)的轻度神经症状患者的当前治疗模式、安全性和结局。方法-从 2010 年 1 月至 2018 年 1 月,127794 例缺血性卒中患者纳入佛罗里达州-波多黎各卒中登记处。发病 24 小时内接受 EVT 的患者根据神经功能缺损程度评分(NIHSS)分为轻度(NIHSS≤5)或中重度(NIHSS>5)。采用多变量逻辑回归评估临床特征和结局的差异。结果-在 4110 例 EVT 患者中(中位数年龄,73 [25%分位数-75]岁;50%为女性),446 例(11%)NIHSS≤5。与 NIHSS>5 相比,NIHSS≤5 的患者到院时间较晚(中位数,138 分钟比 101 分钟),静脉溶栓治疗率较低(30%比 43%),血管内治疗时间较长(中位数,167 分钟比 115 分钟),且更可能在南佛罗里达州治疗(64%比 53%)。多变量分析显示,年龄较轻、私人保险(而非医疗保险)、高血压史、既往独立行走能力和医院规模是 NIHSS≤5 的独立特征。在 NIHSS≤5 的 EVT 患者中,76%出院后回到家中/接受康复治疗,64%出院时能够独立行走,而 NIHSS>5 的患者中分别为 53%和 32%。轻度卒中 EVT 患者症状性颅内出血发生率为 4%,而 NIHSS>5 的患者为 6.4%。结论-尽管缺乏基于证据的推荐,在临床实践中,接受 EVT 的患者中有 11%存在轻度神经症状。根据临床症状严重程度,血管内治疗的患者存在个体、医院和地域差异。我们的数据表明,EVT 治疗轻度卒中患者是安全的,总体结局良好。